<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
doi: 10.1038/ni0402-314
pmid: 11919566
Multiple sources of HSCs exist. Here, Verfaillie discusses the long-term engraftment capabilities of each source and the search for ex vivo expansion conditions to allow bulk culture for therapeutic HSC transplantation.
GROWTH-FACTOR, 3101 Biochemistry and cell biology, Science & Technology, BONE-MARROW, Immunology, HUMAN MARROW-CELLS, Hematopoietic Stem Cell Transplantation, Cell Differentiation, IN-VITRO, RHESUS PERIPHERAL-BLOOD, Hematopoietic Stem Cells, CD34(+) CELLS, 3204 Immunology, HIGH-DOSE CHEMOTHERAPY, HUMAN CORD BLOOD, PROGENITOR CELLS, 1107 Immunology, EX-VIVO EXPANSION, Animals, Humans, Life Sciences & Biomedicine
GROWTH-FACTOR, 3101 Biochemistry and cell biology, Science & Technology, BONE-MARROW, Immunology, HUMAN MARROW-CELLS, Hematopoietic Stem Cell Transplantation, Cell Differentiation, IN-VITRO, RHESUS PERIPHERAL-BLOOD, Hematopoietic Stem Cells, CD34(+) CELLS, 3204 Immunology, HIGH-DOSE CHEMOTHERAPY, HUMAN CORD BLOOD, PROGENITOR CELLS, 1107 Immunology, EX-VIVO EXPANSION, Animals, Humans, Life Sciences & Biomedicine
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 103 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |